{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:24:38Z","timestamp":1790267078427,"version":"4.1.0"},"reference-count":31,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Ventus Charitable Foundation"},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DK121888"],"award-info":[{"award-number":["K23DK121888"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Current evidence on determinants of quality of life (QoL) in patients with adrenal insufficiency (AI) is limited.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This work aimed to identify the determinants of QoL in different subtypes of AI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This multicenter cross-sectional survey study was conducted using a patient-centered questionnaire, the Short Form-36.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 529 participants, 223 (42.2%) had primary AI, 190 (35.9%) had secondary AI, and 116 (21.9%) had glucocorticoid-induced AI. Median age was 58 years (interquartile range: 43-68 years) and 342 (64.8%) were women. In multivariable analyses, patients were more likely to report worse physical scores if they were women (odds ratio [OR]: 3.3; 95% CI, 1.8-6.0), had secondary AI or glucocorticoid-induced AI (OR: 2.5; 95% CI, 1.4-4.3), had shorter duration of AI (OR: 2.0; 95% CI, 1.1-3.6), were treated with more than 25 mg hydrocortisone equivalent daily (OR: 2.3; 95% CI, 1.2-4.6), had more comorbidities related to glucocorticoid excess (OR: 2.3; 95% CI, 1.3-4.0), reported a higher financial burden from AI (OR: 2.1; 95% CI, 1.3-3.6), and reported difficulties with AI management (OR: 2.5; 95% CI, 1.2-5.2). Women (OR: 2.1; 95% CI, 1.08-4.0), shorter duration of AI (OR: 2.4; 95% CI, 1.4-4.3), higher financial burden (OR: 2.3; 95% CI, 1.3-4.0), difficulties with AI management (OR: 2.6; 95% CI, 1.4-4.9), and lack of family support (OR: 9.1; 95% CI, 2.3-33.3) were associated with worse mental component scores.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In patients with AI, QoL could be improved by addressing certain determinants, such as avoiding GC overreplacement, providing in-depth education on self-management, offering more comprehensive insurance coverage, and ensuring better family support.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgac175","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T21:01:12Z","timestamp":1648587672000},"page":"e2851-e2861","source":"Crossref","is-referenced-by-count":28,"title":["Quality of Life and its Determinants in Patients With Adrenal Insufficiency: A Survey Study at 3 Centers in the United States"],"prefix":"10.1210","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-0419","authenticated-orcid":false,"given":"Dingfeng","family":"Li","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, Minnesota 55905 , USA"},{"name":"Endocrinology and Metabolism Institute, Cleveland Clinic , Cleveland, Ohio 44195 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Brand","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, University of Michigan , Ann Arbor, Michigan 48109 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7367-3885","authenticated-orcid":false,"given":"Oksana","family":"Hamidi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center , Dallas, Texas 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh A","family":"Westfall","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center , Dallas, Texas 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malavika","family":"Suresh","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, Minnesota 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2262-0011","authenticated-orcid":false,"given":"Tobias","family":"Else","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, University of Michigan , Ann Arbor, Michigan 48109 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Vaidya","sequence":"additional","affiliation":[{"name":"Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women\u2019s Hospital , Boston, Massachusetts 02115 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-2524","authenticated-orcid":false,"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, Minnesota 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,3,29]]},"reference":[{"issue":"1","key":"2022061616023842900_CIT0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-021-00252-7","article-title":"Adrenal insufficiency","volume":"7","author":"Hahner","year":"2021","journal-title":"Nat Rev Dis Primers."},{"issue":"1","key":"2022061616023842900_CIT0002","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.semarthrit.2016.03.001","article-title":"Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review","volume":"46","author":"Joseph","year":"2016","journal-title":"Semin Arthritis Rheum."},{"key":"2022061616023842900_CIT0003","doi-asserted-by":"crossref","first-page":"n1380","DOI":"10.1136\/bmj.n1380","article-title":"Glucocorticoid induced adrenal insufficiency","volume":"374","author":"Prete","year":"2021","journal-title":"BMJ"},{"issue":"6","key":"2022061616023842900_CIT0004","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1530\/EJE-08-0578","article-title":"Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens","volume":"159","author":"Bleicken","year":"2008","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2022061616023842900_CIT0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2265.2009.03596.x","article-title":"Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency","volume":"72","author":"Bleicken","year":"2010","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"6","key":"2022061616023842900_CIT0006","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/MAJ.0b013e3181db6b7a","article-title":"Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients","volume":"339","author":"Bleicken","year":"2010","journal-title":"Am J Med Sci."},{"issue":"10","key":"2022061616023842900_CIT0007","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1210\/jc.2007-0685","article-title":"Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis","volume":"92","author":"Hahner","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022061616023842900_CIT0008","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1365-2265.2002.01466.x","article-title":"Subjective health status in Norwegian patients with Addison\u2019s disease","volume":"56","author":"L\u00f8v\u00e5s","year":"2002","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"12","key":"2022061616023842900_CIT0009","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1210\/jc.2009-1368","article-title":"Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry","volume":"94","author":"Erichsen","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"2022061616023842900_CIT0010","doi-asserted-by":"crossref","first-page":"718660","DOI":"10.3389\/fendo.2021.718660","article-title":"Sex-specific limitations in physical health in primary adrenal insufficiency","volume":"12","author":"Didriksen","year":"2021","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"3","key":"2022061616023842900_CIT0011","doi-asserted-by":"crossref","first-page":"e1408","DOI":"10.1210\/clinem\/dgaa668","article-title":"Determinants of self-reported health outcomes in adrenal insufficiency: a multisite survey study","volume":"106","author":"Li","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022061616023842900_CIT0012","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform."},{"issue":"3","key":"2022061616023842900_CIT0013","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1067\/S0022-3476(03)00294-4","article-title":"Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency","volume":"143","author":"Punthakee","year":"2003","journal-title":"J Pediatr."},{"issue":"2","key":"2022061616023842900_CIT0014","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"2022061616023842900_CIT0015","article-title":"Supplementary data for \u201cQuality of life and its determinants in patients with adrenal insufficiency: a survey study from 3 tertiary centers in the United States.\u201d","volume-title":"Figshare Digital Repository","author":"Li","year":"2022"},{"key":"2022061616023842900_CIT0016","first-page":"AS264","article-title":"Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study","volume":"33","author":"Ware","year":"1995","journal-title":"Med Care."},{"key":"2022061616023842900_CIT0017","article-title":"SF-36 Physical & Mental Health Summary Scales: A Manual for Users of Version 1.","author":"Ware","year":"2001","edition":"1"},{"issue":"5","key":"2022061616023842900_CIT0018","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1012552211996","article-title":"Do SF-36 summary component scores accurately summarize subscale scores?","volume":"10","author":"Taft","year":"2001","journal-title":"Qual Life Res."},{"issue":"2","key":"2022061616023842900_CIT0019","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1210\/jc.2011-1901","article-title":"Quality of life in European patients with Addison\u2019s disease: validity of the disease-specific questionnaire AddiQoL","volume":"97","author":"\u00d8ksnes","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022061616023842900_CIT0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/cen.14405","article-title":"Evaluating tertiary adrenal insufficiency in rheumatology patients on long-term systemic glucocorticoid treatment","volume":"94","author":"Sagar","year":"2021","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2022061616023842900_CIT0021","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1530\/EJE-17-0251","article-title":"Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritis","volume":"177","author":"Borresen","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"10","key":"2022061616023842900_CIT0022","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/rheumatology\/keaa011","article-title":"Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach","volume":"59","author":"Borresen","year":"2020","journal-title":"Rheumatology (Oxford)."},{"issue":"2","key":"2022061616023842900_CIT0023","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1016\/S2665-9913(20)30389-1","article-title":"Variability in counselling for adrenal insufficiency in COVID-19 and beyond: a survey of rheumatology practice","volume":"3","author":"Mehta","year":"2021","journal-title":"Lancet Rheumatol."},{"issue":"5","key":"2022061616023842900_CIT0024","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1210\/js.2016-1064","article-title":"Health care burden in patients with adrenal insufficiency","volume":"1","author":"Gunnarsson","year":"2017","journal-title":"J Endocr Soc."},{"issue":"12","key":"2022061616023842900_CIT0025","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1210\/jc.2016-2221","article-title":"Exploring inpatient hospitalizations and morbidity in patients with adrenal insufficiency","volume":"101","author":"Stewart","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022061616023842900_CIT0026","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.4065\/83.12.1358","article-title":"Survey-related experiential and attitudinal correlates of future health survey participation: results of a statewide survey","volume":"83","author":"Beebe","year":"2008","journal-title":"Mayo Clin Proc."},{"issue":"5","key":"2022061616023842900_CIT0027","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11102-015-0636-7","article-title":"Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies","volume":"18","author":"Andela","year":"2015","journal-title":"Pituitary."},{"issue":"6","key":"2022061616023842900_CIT0028","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1210\/jc.2004-1375","article-title":"Quality of life in patients after long-term biochemical cure of Cushing\u2019s disease","volume":"90","author":"van Aken","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022061616023842900_CIT0029","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-12-0308","article-title":"Impaired quality of life in patients in long-term remission of Cushing\u2019s syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?","volume":"167","author":"Wagenmakers","year":"2012","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2022061616023842900_CIT0030","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s40618-020-01422-2","article-title":"Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: the CORTI-COVID study","volume":"44","author":"Martino","year":"2021","journal-title":"J Endocrinol Invest."},{"issue":"7","key":"2022061616023842900_CIT0031","doi-asserted-by":"crossref","first-page":"e2469","DOI":"10.1210\/clinem\/dgab334","article-title":"The impact of the COVID-19 pandemic on self-reported outcomes in patients with adrenal insufficiency","volume":"106","author":"Li","year":"2021","journal-title":"J Clin Endocrinol Metab."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac175\/43513938\/dgac175.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/7\/e2851\/44110592\/dgac175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/7\/e2851\/44110592\/dgac175.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T16:08:50Z","timestamp":1655395730000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/7\/e2851\/6555678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,29]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,3,29]]},"published-print":{"date-parts":[[2022,6,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac175","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,3,29]]}}}